.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Covington
Citi
Accenture
Argus Health
Healthtrust
Chubb
QuintilesIMS
Colorcon

Generated: September 24, 2017

DrugPatentWatch Database Preview

CELESTONE Drug Profile

« Back to Dashboard

What is the patent landscape for Celestone, and what generic Celestone alternatives are available?

Celestone is a drug marketed by Merck Sharp Dohme and Schering and is included in five NDAs.

The generic ingredient in CELESTONE is betamethasone acetate; betamethasone sodium phosphate. There are sixty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the betamethasone acetate; betamethasone sodium phosphate profile page.

Summary for Tradename: CELESTONE

Patents:0
Applicants:2
NDAs:5
Bulk Api Vendors: see list47
Clinical Trials: see list11
Patent Applications: see list6,859
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CELESTONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme
CELESTONE
betamethasone
SYRUP;ORAL014215-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
CREAM;TOPICAL014762-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
TABLET;ORAL012657-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
CELESTONE
betamethasone sodium phosphate
INJECTABLE;INJECTION017561-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
CELESTONE SOLUSPAN
betamethasone acetate; betamethasone sodium phosphate
INJECTABLE;INJECTION014602-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CELESTONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
CELESTONE
betamethasone
SYRUP;ORAL014215-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
CREAM;TOPICAL014762-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
TABLET;ORAL012657-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
QuintilesIMS
Queensland Health
US Army
Argus Health
Julphar
McKesson
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot